3-{5-Ethoxycarbonyl-1-[3-(2-oxopyrrolidin-1-yl)propyl]-1H-benzimidazol-2-yl}benzoic acid

3-{5-Ethoxycarbonyl-1-[3-(2-oxopyrrolidin-1-yl)propyl]-1H-benzimidazol-2-yl}benzoic acid

In the title compound, C24H25N3O5, the ethoxy group is disordered over two orientations in a 0.853 (14):0.147 (14) ratio. The benzimadazole ring system (r.m.s. deviation = 0.016 Å) makes a dihedral angle of 35.47 (7)° with the attached benzen...

Full description

Bibliographic Details
Main Authors:	Yeong Keng Yoon, Mohamed Ashraf Ali, Soo Choon Tan, Mohd Mustaqim Rosli, Ibrahim Abdul Razak
Format:	Article
Language:	English
Published:	International Union of Crystallography 2013-02-01
Series:	Acta Crystallographica Section E
Online Access:	http://scripts.iucr.org/cgi-bin/paper?S1600536813001116

Similar Items

Ethyl 2-[5-(4-fluorophenyl)pyridin-3-yl]-1-[3-(2-oxopyrrolidin-1-yl)propyl]-1H-benzimidazole-5-carboxylate
by: Keng Yoon Yeong, et al.
Published: (2013-07-01)

Ethyl 1-[3-(2-oxopyrrolidin-1-yl)propyl]-2-phenyl-1H-benzimidazole-5-carboxylate
by: Yeong Keng Yoon, et al.
Published: (2012-02-01)

Ethyl 2-(4-nitrophenyl)-1-[3-(2-oxopyrrolidin-1-yl)propyl]-1H-benzimidazole-5-carboxylate
by: Yeong Keng Yoon, et al.
Published: (2012-01-01)

Ethyl 2-(4-methoxyphenyl)-1-[3-(2-oxopyrrolidin-1-yl)propyl]-1H-benzimidazole-5-carboxylate
by: Yeong Keng Yoon, et al.
Published: (2012-02-01)

Ethyl 2-(1,3-benzodioxol-5-yl)-1-[3-(2-oxopyrrolidin-1-yl)propyl]-1H-benzimidazole-5-carboxylate
by: Yeong Keng Yoon, et al.
Published: (2012-02-01)

Ethyl 2-[4-(morpholin-4-yl)phenyl]-1-[3-(2-oxopyrrolidin-1-yl)propyl]-1H-1,3-benzimidazole-5-carboxylate monohydrate
by: Yeong Keng Yoon, et al.
Published: (2012-10-01)

Ethyl 2-(4-hydroxy-3-methoxyphenyl)-1-[3-(2-oxopyrrolidin-1-yl)propyl]-1H-benzimidazole-5-carboxylate monohydrate
by: Yeong Keng Yoon, et al.
Published: (2012-01-01)

Ethyl 2-(1,3-benzodioxol-5-yl)-1-[3-(1H-imidazol-1-yl)propyl]-1H-benzimidazole-5-carboxylate
by: Yeong Keng Yoon, et al.
Published: (2012-01-01)

Ethyl 2-(4-bromophenyl)-1-[3-(1H-imidazol-1-yl)propyl]-1H-benzimidazole-5-carboxylate monohydrate
by: Yeong Keng Yoon, et al.
Published: (2011-11-01)

2-[3-(1H-Benzimidazol-2-yl)propyl]-1-decyl-1H-benzimidazole
by: Hamid Ennajih, et al.
Published: (2011-09-01)

Ethyl 1-[2-(morpholin-4-yl)ethyl]-2-[4-(morpholin-4-yl)phenyl]-1H-1,3-benzimidazole-5-carboxylate
by: Yeong Keng Yoon, et al.
Published: (2011-07-01)

Crystal structure of 2-oxopyrrolidin-3-yl 4-(2-phenyldiazen-1-yl)benzoate
by: Igor Elkin, et al.
Published: (2018-04-01)

2-[1-(3-Oxo-1,3-dihydro-2-benzofuran-1-yl)-1H-benzimidazol-2-yl]benzoic acid methanol solvate
by: Guang Shi, et al.
Published: (2010-08-01)

Crystal structure of 4-[4-(ethoxycarbonyl)piperazin-1-yl]benzoic acid
by: Md. Serajul Haque Faizi, et al.
Published: (2016-09-01)

(3RS)-S-[1-(3-Chlorophenyl)-2-oxopyrrolidin-3-yl]thiouronium bromide
by: Aleš Ružička, et al.
Published: (2009-02-01)

1-Benzyl-2-(1H-indol-3-yl)-5-oxopyrrolidine-2-carbonitrile
by: Raymond Schinazi, et al.
Published: (2008-02-01)

Methyl 3-[(1H-benzimidazol-1-yl)methyl]-1-methyl-4-(4-methylphenyl)-2&#8242;-oxopyrrolidine-2-spiro-3&#8242;-1-benzimidazole-3-carboxylate
by: S. Kathiravan, et al.
Published: (2010-10-01)

Tert-Butyl 5-(4-methoxy-phen-yl)-1-methyl-2-oxopyrrolidin-3-yl carbonate
by: Chantrapromma, S., et al.

Crystal structure of 1-benzyl-2-hydroxy-5-oxopyrrolidin-3-yl acetate
by: Ignez Caracelli, et al.
Published: (2015-08-01)

tert-Butyl 5-(4-methoxyphenyl)-1-methyl-2-oxopyrrolidin-3-yl carbonate
by: Suchada Chantrapromma, et al.
Published: (2008-04-01)

tert-Butyl 5-(4-methoxyphenyl)-1-methyl-2-oxopyrrolidin-3-yl carbonate
by: Chantrapromma, S, et al.

Propyl 2-(1H-indol-3-yl)acetate
by: Guo-Min Tang, et al.
Published: (2013-11-01)

Bis[1,3-bis(1-propyl-1H-benzimidazol-2-yl)-2-oxapropane]cadmium(II) dipicrate dimethylformamide monosolvate
by: Bin Liu, et al.
Published: (2011-10-01)

(3RS)-S-[1-(3-Chlorophenyl)-2-oxopyrrolidin-3-yl]-N,N′-dimethylthiouronium bromide
by: Aleš Ružička, et al.
Published: (2009-02-01)

Synthesis, Characterization and Bioassay of Novel Substituted 1-(3-(1,3-Thiazol-2-yl)phenyl)-5-oxopyrrolidines
by: Birutė Sapijanskaitė-Banevič, et al.
Published: (2020-05-01)

(E)-1,2-Bis(1-propyl-5,6-dimethyl-1H-benzimidazol-2-yl)ethene
by: Joseph A. Potenza, et al.
Published: (2010-03-01)

Orthorhombic polymorph of 4-[(1H-benzimidazol-1-yl)methyl]benzoic acid
by: Hai-Wei Kuai, et al.
Published: (2011-11-01)

Monoclinic polymorph of 4-[(1H-benzimidazol-1-yl)methyl]benzoic acid
by: Xiao-Chun Cheng, et al.
Published: (2011-10-01)

Crystal structure, Hirshfeld and electronic transition analysis of 2-[(1H-benzimidazol-1-yl)methyl]benzoic acid
by: Arif Ali, et al.
Published: (2021-07-01)

Crystal structure of (S)-2-(2-oxopyrrolidin-1-yl)butanoic acid, C8H13NO3
by: Liu Yin-Qiu, et al.
Published: (2009-04-01)

Crystal structure of (S)-2-(2-oxopyrrolidin-1-yl)butanoic acid, C8H13NO3
by: Liu Yin-Qiu, et al.
Published: (2009-12-01)

Ethyl 2-[4-(dimethylamino)phenyl]-1-phenyl-1H-benzimidazole-5-carboxylate
by: Keng Yoon Yeong, et al.
Published: (2013-06-01)

2-[3-(1H-Benzimidazol-2-yl)propyl]-1H-benzimidazol-3-ium 3,5-dicarboxybenzoate&#8211;benzene-1,3,5-tricarboxylic acid&#8211;water (1/1/1)
by: Guo-dong Feng, et al.
Published: (2010-11-01)

Ethyl 1-[2-(morpholin-4-yl)ethyl]-2-[4-(trifluoromethyl)phenyl]-1H-benzimidazole-5-carboxylate
by: Yeong Keng Yoon, et al.
Published: (2011-05-01)

3-[1-(3-Hydroxybenzyl)-1H-benzimidazol-2-yl]phenol
by: Naser Eltaher Eltayeb, et al.
Published: (2009-06-01)

3-(1H-1,3-Benzimidazol-2-yl)-2,7-dimethoxyquinoline
by: Hayette Alliouche, et al.
Published: (2012-08-01)

(E)-2-[4-(Piperidin-1-yl)benzylidene]-2,3-dihydro-1H-inden-1-one
by: Mohamed Ashraf Ali, et al.
Published: (2010-11-01)

2-(1,3-Benzodioxol-5-yl)-1H-benzimidazole
by: Nadir Ghichi, et al.
Published: (2014-02-01)

1-[2,3-Bis(tetradecyloxy)propyl]-3-[2-(piperazin-1-yl)ethyl]urea
by: Santiago Grijalvo, et al.
Published: (2015-11-01)

1,3-Bis(1H-benzimidazol-2-yl)-2-oxapropane
by: Huilu Wu, et al.
Published: (2009-05-01)

Cannot write session to /tmp/vufind_sessions/sess_5grht4sabh95dr5vhnuaubup19